Comparison of weekly and daily recall of pain as an endpoint in a randomized phase 3 trial of cabozantinib for metastatic castration-resistant prostate cancer
10.1177/17407745211009547
Saved in:
Main Authors: | , , , |
---|---|
其他作者: | |
格式: | Article |
出版: |
SAGE Publications
2023
|
主題: | |
在線閱讀: | https://scholarbank.nus.edu.sg/handle/10635/239598 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
機構: | National University of Singapore |